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Abstract
Background Two randomised trials assessing the effectiveness of decompressive craniectomy (DC) following traumatic brain
injury (TBI) were published in recent years: DECRA in 2011 and RESCUEicp in 2016. As the results have generated debate
amongst clinicians and researchers working in the field of TBI worldwide, it was felt necessary to provide general guidance on
the use of DC following TBI and identify areas of ongoing uncertainty via a consensus-based approach.
Methods The International Consensus Meeting on the Role of Decompressive Craniectomy in the Management of Traumatic Brain
Injury took place inCambridge,UK, on the 28th and 29th September 2017. Themeetingwas jointly organised by theWorld Federation
of Neurosurgical Societies (WFNS), AO/Global Neuro and the NIHR Global Health Research Group on Neurotrauma. Discussions
and voting were organised around six pre-specified themes: (1) primary DC for mass lesions, (2) secondary DC for intracranial
hypertension, (3) peri-operative care, (4) surgical technique, (5) cranial reconstruction and (6) DC in low- andmiddle-income countries.
Results The invited participants discussed existing published evidence and proposed consensus statements. Statements required
an agreement threshold of more than 70% by blinded voting for approval.
Conclusions In this manuscript, we present the final consensus-based recommendations. We have also identified areas of
uncertainty, where further research is required, including the role of primary DC, the role of hinge craniotomy and the optimal
timing and material for skull reconstruction.
Keywords Neurosurgery . Neurotrauma . Decompression . Cranioplasty
Introduction
Traumatic brain injury (TBI) is a major public health and
socioeconomic problem around the world. According to the
World Health Organisation (WHO), more than 5 million peo-
ple die every year as a result of trauma, accounting for 9% of
the world’s deaths. Trauma also results in millions of non-fatal
injuries leading to life-long disability [90]. Of all the types of
traumatic injuries, those to the brain are the most likely to
result in death or permanent disability [102]. It is estimated
that 69million (95%CI 64–74million) individuals worldwide
suffer a TBI each year. However, the true burden of TBI and
its sequelae appears to be underestimated owing to incomplete
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capture of data, especially in low- and middle-income coun-
tries (LMICs) [79]. Nevertheless, LMICs face almost three
times more cases of TBI proportionally than high-income
countries (HICs).
Multiple large cohort studies of TBI patients have demonstrat-
ed intracranial hypertension to be independently associated with
a higher risk of death and poor outcome following TBI [3,4,31].
Consequently, management of brain swelling and elevated intra-
cranial pressure (ICP) is a key component of acute TBI care [14].
A foundation of current protocols and guidelines in TBI is the
treatment and prevention of pathological elevation in ICP, which
can compromise cerebral perfusion and lead to further neurolog-
ical compromise and life-threatening brain herniation.
Decompressive craniectomy (DC) is a neurosurgical procedure
that involves removal of a section of the skull (‘bone flap’) and
opening of the underlying dura. From a physiological viewpoint,
it provides additional space for the swollen brain to decompress,
leading to reduction in ICP and maintained or improved cerebral
compliance [9, 99]. Described more than a century ago by
Theodor Kocher [47], the utility of the procedure and its effect
on patient outcome were perpetually questioned, and it went in
and out of fashion throughout the twentieth century. DC is a
major operation associated with significant early and late com-
plications including seizures, subdural hygroma, hydrocephalus,
and infection. Furthermore, it necessitates an additional operation
for cranial reconstruction, termed cranioplasty, which is also as-
sociated with significant morbidity. Until this decade, the dearth
of high-quality outcome data from randomised controlled trials
caused uncertainty about the efficacy of DC, and DC did not
feature in the Third Edition of the Brain Trauma Foundation
Guidelines for TBI Management in 2007 [10].
In the last 10 years, the TBI community has witnessed
considerable research efforts, including several randomised
trials, to address such aspects of DC as surgical technique,
timing and indications in different patient populations. Two
of the trials were international and addressed distinct clinical
questions. DECRA [24] assessed the efficacy of
bifrontotemporoparietal DC in adult TBI patients with diffuse
brain injury (i.e. no mass lesion requiring surgical evacuation)
in whom first-tier intensive care and neurosurgical therapies
had not maintained ICP below accepted targets. RESCUEicp
[37] assessed the efficacy of DC after first- and second-tier
therapies had failed to control refractory and sustained intra-
cranial hypertension in TBI patients. The results of both trials
sparked further debate in the TBI community worldwide.
There was a palpable need for a consensus meeting to provide
general guidance on the use of DC following TBI and to
identify areas of ongoing uncertainty.
The International Consensus Meeting on the Role of
Decompressive Craniectomy in the Management of
Traumatic Brain Injury was organised jointly by the World
Federation of Neurosurgical Societies (WFNS), AO/Global
Neuro and the NIHR Global Health Research Group on
Neurotrauma and hosted at the University of Cambridge on
the 28th and 29th September 2017.
Methods
Delegates were invited to participate in the consensus meeting
based on their experience and contributions to the literature on
DC and/or TBI. The aim was to invite approximately 50 del-
egates with a broad geographic representation. The various
topics of the consensus meeting were grouped into six themes
to aid structured discussion and consensus building. The six
themes were (i) primary DC for mass lesions, (ii) secondary
DC for intracranial hypertension, (iii) peri-operative care of
patients undergoing DC, (iv) surgical technique, (v) cranial
reconstruction following DC and (vi) DC in LMICs.
The meeting took place over 2 days. On the first day, del-
egates worked in six small groups, coordinated by two facil-
itators, with the aim of discussing the relevant literature, iden-
tifying areas of agreement/disagreement and eventually gen-
erating approximately 10 relevant recommendations for clin-
ical practice and areas of uncertainty for future research. On
the second day, all delegates initially listened to the small
group facilitators outlining key points from their small group’s
discussion and presenting the proposed recommendations,
elaborating as necessary. Each small group presentation was
followed by floor discussion which provided the opportunity
for all delegates to debate the recommendations proposed by
the small groups and refine them if necessary prior to anony-
mous voting. Anonymous real-time voting of all proposed
recommendations with the participation of all delegates took
place with the use of audience engagement software (Glisser
Limited, London, UK). When voting as to whether to include
each proposed recommendation in the final consensus state-
ment, the three options were ‘agree’, ‘uncertain’ and ‘dis-
agree’. The threshold for including a recommendation in the
final statement was a supermajority of 70% of delegates in
agreement. Additionally, recommendations which during the
first round of voting gathered levels of agreement close to
70% (i.e. just above or just below), high levels of uncertain
responses or similar levels of agreement and disagreement
were refined following floor discussion and put to a second
round of voting. Following each statement, we present the
percentage level of agreement followed by the ratio of partic-
ipants voting in favour to the total number of participants
casting their vote.
For the purpose of the consensus statement, we performed
a literature search in PubMed using decompressive
craniectomy and traumatic brain injury as key words.
Bibliographies of retrieved reports were then searched for ad-
ditional references. Only articles published in the English lan-
guage were included.
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Results (including discussion and consensus
statements)
Primary DC for mass lesions
Primary DC refers to leaving a bone flap out after evacuating
an intracranial mass lesion: an extradural, subdural and/or an
intraparenchymal traumatic haematoma or contusion. The ra-
tionale is to control ICP in the post-operative period. The
disadvantage is that later skull reconstruction is required.
Traumatic haematomas are present in approximately 45% of
severe TBI cases [11, 12, 13]. DC is a treatment option fol-
lowing evacuation of mass lesion at initial craniotomy, but the
exact indications require further refinement.
Extradural/epidural haematomas (EDH) occur in approxi-
mately 2% of all head injuries and usually present as isolated
lesions without significant intraparenchymal swelling. The
Brain Trauma Foundation (BTF) guidelines on the manage-
ment of EDH recommend craniotomy and evacuation for all
patients with an EDH volume of greater than 30 ml regardless
of Glasgow coma scale (GCS) score [11]. The Milan
Consensus Conference on Clinical Applications of
Intracranial Pressure Monitoring in Traumatic Brain Injury
in 2014 reviewed evidence on ICP trends following evacua-
tion of isolated EDH and found that there is low risk of intra-
cranial hypertension developing [94], suggesting that DC is
not routinely required for treatment of isolated EDH.
Acute subdural haematomas (ASDH) can be treated surgi-
cally with craniotomy (bone replaced) or DC (bone left out).
They are present in approximately one third of severe TBI
patients, but two thirds of TBI patients undergoing surgery
(excluding external ventricular drain and ICP monitoring in-
sertion) have an ASDH evacuated [22]. ASDHs are often
associated with presence of intraparenchymal contusions or
haematomas and with a propensity for brain swelling [22,
83, 88, 89]. BTF guidelines recommend immediate operative
intervention if ASDH thickness is more than 10 mm or mid-
line shift is greater than 5 mm regardless of the GCS score.
They also recommend that patients with GCS scores less than
9, even if the thickness of ASDH is less than 10 or midline
shift less than 8 mm, should undergo emergent surgical evac-
uation of the lesion if the GCS score decreases by 2 or more
points from the time of injury to the time of hospital admis-
sion, or if the patient presents with asymmetric or fixed and
dilated pupils [12]. BTF guidelines recommend that surgical
evacuation should be performed using a craniotomy with or
without replacement of the bone flap, but do not specify the
exact indications for craniectomy. There are variations in clin-
ical practice around the world when it comes to ASDH evac-
uation, with some neurosurgeons performing primary DC
more readily and more frequently than others. Two interna-
tional surveys of practices found primary DC to be performed
most frequently because the brain is bulging beyond the inner
table of the skull intraoperatively, preventing the safe replace-
ment of the bone flap, or because there is concern that the
brain may swell further in the post-operative period,22,49.
Early studies evaluating ICP following craniotomy for
ASDH evacuation found that a significant proportion of pa-
tients develops intracranial hypertension postoperatively. A
study by Miller and colleagues [62] showed that two-thirds
of the 48 patients with an evacuated acute SDH had intracra-
nial hypertension in the postoperative period (defined as per-
sistently raised ICP above 20 mmHg), with just over half of
those patients developing uncontrollable intracranial hyper-
tension leading to herniation and death. In the series of
Wilberger and colleagues [110], which examined 101 coma-
tose patients who had a craniotomy for ASDH, 43% had
sustained intracranial hypertension that was uncontrolled with
standard therapy. The mortality in this group was 95% com-
pared to 40% in the group of patients whose ICP remained
under 20 mmHg. The theoretical advantage of DC would
therefore be ICP reduction. However, it is not yet clear wheth-
er this necessarily translates into improved functional out-
comes in all patient groups. To date, there is no published class
1 evidence. A number of retrospective observational studies
and case series have compared the effectiveness of craniotomy
and primary craniectomy in patients with ASDH, with con-
flicting conclusions. Some of the studies found worse out-
comes in patients undergoing DC [16, 44, 56, 103, 112] whilst
other studies did not reach the same conclusions [32, 33, 38,
58, 113]. These studies often had significant differences be-
tween the treatment groups, as patients who underwent prima-
ry DC tended to be the ones who had characteristics sugges-
tive of more severe TBI: lower GCS score, thicker ASDH and
greater midline shift as well as more significant extracranial
injuries [32, 33, 38, 44, 58, 112, 113]. Thus, in the absence of a
randomisation process, there is an obvious selection bias
which makes generalisation of these findings difficult. More
recently, a new research method has emerged, termed non-
experimental clinical effectiveness research, which aims to
utilise the heterogeneity in systems, practices and outcomes
in order to compare the effectiveness of interventions that may
be standard practice in some centres or systems, but not in
others. One such study by Hartings and colleagues [33] com-
pared practices and outcomes between two neurosurgical cen-
tres and found postoperative ICP to be better controlled and
patient outcomes better in the centre with greater utilisation of
primary DC. They also found that patients requiring evacua-
tion of subdural hematomas and contusions may benefit from
DC in conjunction with lesion evacuation, evenwhen elevated
ICP is not a factor in the decision to perform surgery [33].
The RESCUE-ASDH study is a multicentre, pragmatic,
parallel group randomised trial which aims to compare the
clinical and cost effectiveness of primary DC versus craniot-
omy for the management of adult head-injured patients under-
going evacuation of an ASDH [48, 76]. The trial includes
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adult head-injured patients (16 years of age and above) who
have an ASDH on CT (patients with additional lesions such as
intracerebral haemorrhage and contusions can be included)
and the admitting neurosurgeon feels that the ASDH needs
to be evacuated either by a craniotomy or DC with the bone
flap of at least 11 cm in both instances. Exclusion criteria are
bilateral ASDHs both requiring evacuation, previous enrol-
ment in RESCUE-ASDH study or severe pre-existing physi-
cal or mental disability or severe comorbidity which would
lead to a poor outcome even if the patient made a full recovery
from the head injury. Eligible patients are randomised to cra-
niotomy or DC intraoperatively after evacuating the ASDH.
Patients with significant brain swelling preventing safe re-
placement of the bone flap are not suitable for randomisation
and are being followed up in an observational cohort. The
primary outcome measure is the extended Glasgow outcome
scale (GOSE) at 12-month post-injury [48, 76]. Recruitment
for the study will complete in 2019.
DC is associated with significant morbidity and necessi-
tates an additional operation (cranioplasty) to reconstruct the
cranium. An introduction of an alternative surgical method to
DC, termed hinge craniotomy, has gained traction in the last
10 years. Hinge craniotomy is a surgical procedure whereby
the bone flap is replaced before closure in such way that it is
secured at one bone edge with a titanium plate attachment, and
the other edges of the bone flap have a plate attachment se-
cured only on the bone flap (but not connected to the cranial
bone edge). This allows the bone flap to expand outward, but
prevents it from sinking inward toward the brain [84]. Several
retrospective studies are now available looking at mixed co-
horts of DC patients (TBI and stroke) which demonstrate ICP
control comparable to DC [41,46,84]. Additional good-
quality studies are required to assess the effect on outcomes
[50].
There are variations in clinical practice regarding use of
continuous ICP monitoring following primary DC [49].
There is no class I evidence available, but retrospective obser-
vational studies looking specifically at ICP trends following
DC support its use [70]. Picetti and colleagues [70] conducted
a retrospective analysis of prospectively collected data on ICP,
CPP and functional outcome in patients following primary
DC. The authors have found that episodes of intracranial hy-
pertension associated with low CPP occur frequently after
primary DC. These were associated with unfavourable neuro-
logical outcome. They found that, despite DC, there was still a
correlation between raised ICP and poor functional outcome.
They conclude that ICPmonitoring is clinically useful in guid-
ing therapy after primary DC [70].
Penetrating brain injury (PBI) was briefly discussed during
the consensus meeting. The meeting delegates acknowledged
the pathophysiology of penetrating brain injury to be different
from that of blunt injury. There are no clinical trials to date to
assess the role of DC in PBI. Practice is based on case series
and has been driven by recent extensive military experience.
Brain swelling is often severe, and intracranial hypertension
can be relieved by large DC. Generally, early wide DC seems
to be in use for severe TBI with diffuse pathology [6, 8, 26, 68,
74, 78].
Consensus statements concerning primary DC for mass
lesions
1. After evacuating an acute subdural haematoma (ASDH),
if the brain is bulging beyond the inner table of the skull
intra-operatively, consider leaving the bone flap out
based upon clinical and radiographic findings (100%;
49/49)
2. After evacuating an ASDH, if the brain is very relaxed
and the pre-operative computed tomography (CT) imag-
ing is not in keeping with a high risk of progressive brain
swelling (i.e. no or minimal parenchymal injury), the
bone flap should be replaced (e.g. elderly patient, low-
energy mechanism). (87.8%; 43/49)
3. For the intermediate category of ASDH patients (brain
neither very relaxed, nor bulging), surgeon judgement
must be used to decide whether to leave the bone flap
out or not. (97.9%; 47/48)
4. After evacuating an isolated epidural haematoma, the
bone flap, in general, should be replaced (87.8%; 43/49)
5. In a primary DC, the bone flap should be of large size, at
least 12 cm × 15 cm (93.9%; 46/49)
6. DC is an option for patient with contusions in whom
contusions are not being evacuated (83.3%; 40/48)
7. If well-circumscribed contusions/intraparenchymal
haematoma are present, surgeon judgement should be
used to decide whether to evacuate the contusions/
intraparenchymal haematomas (95.8%; 46/48)
8. When the bone is replaced, an ICP monitor should be
placed where available (74.5%; 35/47)
9. An ICP monitor should be placed following primary
DC, if available (77.1%; 37/48)
10. In situations where no invasive/continuous ICP monitor-
ing is available, computed tomography (CT) imaging
should be used to monitor progress (97.9%; 47/48)
Areas of uncertainty regarding primary DC for mass lesions
1. For intermediate category of ASDH patient, where fol-
lowing evacuation of ASDH, brain is neither relaxed nor
bulging, it is not clear if performing DC instead of replac-
ing a bone flap provides any additional benefits for the
patient. The results of the RESCUE-ASDH trial are
awaited.
2. The use of hinge craniotomy requires further evaluation to
determine effects on outcome.
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Secondary DC
A secondary DC is typically used as part of tiered therapeutic
protocols that are frequently used in intensive care units
(ICUs) in order to control raised ICP after TBI. A secondary
DC can be undertaken as last-tier life-saving therapy for pa-
tients with refractory intracranial hypertension (i.e. when all
other measures have failed to reduce ICP) or as a second-tier
therapy in patients with less pronounced elevation of ICP (i.e.
as a neuro-protective measure).
Studies in patients undergoing secondary DC found it to be
e f f ec t i ve in reduc ing ICP and improv ing CPP
[1,19,24,29,34,37,52,64,66,67,82,85,100,108], reducing the
cumulative ischaemic burden and therapy intensity level
[106]. The effect of secondary DC on functional outcomes is
not as straightforward. Many observational studies and case
series attempted to address the question, with wide variation in
reported outcomes. This is not surprising given that they in-
clude very heterogeneous populations and measure outcomes
at different time points using different outcome measures.
There are only a handful of international (multicentre),
randomised trials.
Randomised controlled trials on secondary DC
The first randomised controlled trial (RCT) of early secondary
DC for TBI was performed in paediatric patients [97].
Twenty-seven children (median age, 120.9 months; range,
13.6–176.4 months) with head injuries were randomly
assigned to receive medical management alone or medical
management plus bitemporal DC (removal of a disc of tem-
poral bone measuring about 3–4 cm, with extension of the
craniectomy to the floor of the middle cranial fossa; dura ma-
ter was not open). The study showed that DC patients are more
likely to have better ICP control with lower ICP values fol-
lowing DC and fewer episodes of intracranial hypertension,
and functional outcome and quality of life may be better than
in children treated with medical management alone (P =
0.046; owing to multiple significance testing P < 0.0221 is
required for statistical significance).
Results of the Decompressive Craniectomy in Diffuse
Brain Injury (DECRA) international, multicentre RCT were
published in 2011 [24]. Between December 2002 and April
2010, the trial collaborators randomly assigned 155 adults
with severe diffuse TBI to either bifrontotemporoparietal DC
or standard (medical) treatment if they developed intracranial
hypertension defined as ICP of more than 20 mmHg for more
than 15 min in a 1-h period refractory to first-tier therapies
[24]. The original primary outcome was an unfavourable out-
come (a composite of death, vegetative state, or severe dis-
ability), as evaluated on the Extended Glasgow Outcome
Scale 6 months after injury. Patients in the DC group had less
time with ICPs above the treatment threshold (p < 0.001),
fewer interventions for increased ICP (p < 0.02 for all com-
parisons), and fewer days in the ICU (p < 0.001). However,
better ICP control did not translate into improved outcomes
for the DC patients. Mortality was similar in the two treatment
groups (19% in DC group and 18% in control group), but
unfavourable outcome (composite of death, vegetative state
or severe disability, GOS-E 1–4) was higher in the DC group
compared to the control group (70% vs 51%; odds ratio, 2.21;
p = 0.02). While the two groups were well-matched for most
variables, there was a higher proportion of patients with bilat-
eral unreactive pupils in the DC group (27% vs 12% in the
medical treatment group; p = 0.04). Following post hoc ad-
justment for baseline pupil reactivity, there was no difference
in the rates of unfavourable outcomes between the two treat-
ment groups [24].
Randomised Evaluation of Surgery with Craniectomy for
Uncontrollable Elevation of Intracranial Pressure
(RESCUEicp), an international, multicenter, parallel-group,
superiority RCT, compared last-tier secondary DC with con-
tinued medical management for refractory intracranial hyper-
tension after TBI [37]. The trial included patients with TBI
aged between 10 and 65 years, with an abnormal computed
tomography scan of the brain, an ICP monitor in place and
raised ICP of more than 25 mmHg for 1 to 12 h, despite
applying stage 1 and 2 measures of the ICP protocol (for
details on protocol, see reference 37). The surgical treatment
was either large unilateral frontotemporo-arietal craniectomy
(hemicraniectomy) or bifrontal craniectomy. The primary out-
come measure was the Extended Glasgow Outcome Scale
(GOSE) at 6 months after randomisation. Four hundred and
eight patients were recruited to this trial: 206 were randomised
to the surgical and 202 to the medical group. No significant
between-group variability was observed in terms of baseline
characteristics and medical or surgical treatment given prior to
randomisation. At 6 months, the DC group had a significantly
lower mortality rate compared to the medical group (26.9 vs
49.9%). Surgery was found to be associated with higher rates
of vegetative state, lower severe disability and upper severe
disability than medical management, but the rates of moderate
disability and good recovery were comparable between the
groups [37]. The trial pre-specified favourable outcome as
upper severe disability or better on the GOSE and with such
a pre-specified sensitivity analysis, 42.8% of surgical patients
had a favourable outcome compared to 34.6% of medical
patients (p = 0.12). The same pre-specified sensitivity analysis
at 12 months showed that 45.4% of surgical patients had a
favourable outcome compared to 32.4% of medical patients
(p = 0.01). The trial also showed that control of ICP was better
in the surgical than the medical group.
The 4th Edition of the BTF guideline [14] does not recom-
mend ‘bifrontal DC to improve outcomes as measured by the
GOSE score at 6 months post-injury in severe TBI patients
with diffuse injury (without mass lesions), and with ICP
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elevation to values > 20mmHg for more than 15min within a
1-h period that are refractory to first-tier therapies’. This rec-
ommendation is based on level IIa evidence from a single
class 1 study [DECRA [24]]. The guidelines also acknowl-
edge that DC is a new topic in the 4th Edition of the BTF
Guidelines for theManagement of Severe TBI and that as they
were published before the publication of the RESCUEicp trial,
the trial results will be included in a future guideline update
[14].
Consensus statements concerning secondary DC
1. Where available, ICP monitoring is needed as a
component of decision making for secondary DC
(95.7%; 45/47)
2. Secondary DC is effective in decreasing ICP, but under-
lying brain pathology and pathophysiology contribute to
overall outcome (95.8%; 46/48)
3. The optimal candidate for secondary DC is a patient
whose ICP elevation is the primary contributor to poor
outcome and the primary injury is deemed compatible
with acceptable recovery (97.9%; 46/47)
4. Where available, ICP monitoring should be used in con-
junction with CT findings and neurological exam to de-
cide on secondary DC (100%; 47/47)
5. Use of ICP monitoring is recommended according to
regional availability of resources; non-invasive monitor-
ing methods to establish refractory intracranial hyperten-
sion can be used (79.2%; 38/48)
6. While secondary DC is a potentially useful operation,
it should be applied selectively as there is uncertainty
as to which severe TBI subgroups will truly benefit
(87.5%; 42/48)
7. DC may decrease mortality. However, it is not benign
and is associated with significant risks of complica-
tions and potentially increased risks of disability
(93.8%; 45/48)
8. Before contemplating secondary DC, providers should
conduct frank discussions with family members/
surrogates regarding the risks, benefits, alternatives and
potential prognosis (97.9%; 46/47)
9. Simple and standard ICP thresholds alone are not suffi-
cient to determine eligibility for secondary DC.
Sustained, refractory ICP elevations in conjunction with
other clinical parameters (e.g. examination, imaging,
non-invasive technologies, other monitoring modalities,
status of underlying brain physiology) should be consid-
ered when making the decision to perform secondary
DC (95.7%; 45/47)
10. ICP monitoring should continue after secondary DC.
Thresholds for intervention after decompression may
be reconsidered (76.6%; 36/47)
11. We recommend a large DC with opening of the dura to
effectively reduce ICP and reduce incidence of second-
ary cortical injury from reduced venous drainage
(91.5%; 43/47)
12. Bifrontal or unilateral DC are options in the surgical
treatment of diffuse TBI (95.6%; 44/46)
Peri-operative care
The BTF guidelines (4th Edition) recommend management
of severe TBI patients using information from ICP moni-
toring to reduce in-hospital and 2-week post-injury mortal-
ity [7]. The accepted threshold for treatment is 20 mmHg
[14, 94]. Further, it is the burden of intracranial hyperten-
sion (duration as well as severity) that is related to poor
outcomes [14, 31, 40, 94].
Chesnut and colleagues [17] conducted a multicentre
randomised controlled trial that compared outcomes for pa-
tients whose treatment was informed by continuous (invasive)
ICP monitoring with those whose treatment was informed by
serial imaging (157 patients) and clinical examination (167
patients). This high-quality study found that 6-month out-
comes for patients managed with information from clinical
assessment do not differ from those for patients managed with
information from the ICP monitor [17]. Patients in both
arms received protocolised tiered ICP-lowering therapies,
and 30% of patients in each arm received a DC. It is
important to emphasise that this trial does not challenge
the fundamental concept that brain oedema and raised ICP
should be actively managed in patients with TBI (with
medical and/or surgical means).
Consensus statements concerning peri-operative care
1. Think of ICP as a dose—hours for ICP 25–30 mmHg,
minutes for ICP 30–40 mmHg (78.4%; 40/51)
2. Full escalation of treatment should be achieved before
DC, unless clinical deterioration prompts more urgent
surgery (93.6%; 44/47)
3. Follow usual local protocols for major cranial surgery
with regards to haemostasis and antibiotics (97.9%; 46/
47)
4. Maintain ICP therapy during surgery and immediately
post-DC unless limiting side effects (86.3%; 44/51)
5. If ICP is well controlled by DC:
& the treatment bundle for intracranial hypertension
should not be immediately terminated or altered after
DC (82.4%; 42/51)
& a postoperative CT within 24 h of surgery is recom-
mended to document DC effectiveness and document
complications (80.4%; 41/51)
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6. Continue ICP monitoring and ICP therapy till ICP known
to be controlled and stable; de-escalation should be staged
with sodium normalisation last (80.4%; 41/51)
7. If ICP is not controlled by DC:
& Continue therapy if there is no change in salvageabil-
ity as assessed by pupils, clinical state and CT head
imaging (91.5%; 43/47)
& Look for reversible reasons for intracranial hyperten-
sion (electroencephalogram, CSF circulation disor-
ders) (96.1%; 49/51)
& Consider brief sedation hold to assess neurologic ex-
am, accepting mild intracranial hypertension (78.7%;
37/47)
8. If uncontrollable intracranial hypertension occurs follow-
ing DC, re-assess the situation and treatment goals (98%;
50/51)
Surgical technique in DC
There are three main approaches to secondary DC: bifrontal
craniectomy, unilateral frontotemporoparietal craniectomy
(hemicraniectomy) and bilateral hemicraniectomy. Once the
bone is removed, the dura is opened to relieve intracranial
hypertension.
Reithmeier and colleagues [75], in a study in five patients
undergoing DC, elegantly showed reduction in ICP and in-
crease in brain tissue oxygen tension (PbtO2) and CPP with
every step of DC: removal of bone flap, opening of the dura
and skin closure. After removing the bone flap, ICP values
dropped to physiological values (mean: 7.4 mmHg), whereas
PbtO2 values increased only slightly (mean: 11 mmHg).
Opening of the dura resulted in a further decrease of ICP
(mean 4.8 mmHg) and an increase of PbtO2 to normal limits
(mean: 18.8 mmHg). After skin closure, mean ICP was
6.8 mmHg and mean ptiO2 was 21.7 mmHg, respectively.
They found a significant decrease of ICP after craniectomy
(p < 0.042) and after dura enlargement (p < 0.039) as well as a
statistically significant increase in PbtO2 after craniectomy
(p < 0.043) and after dura enlargement (p < 0.041). The results
suggest that dura enlargement is the crucial step to restore
adequate brain tissue oxygenation [75].
Two RCTs, one multicentre [39] and one single-centre
[73], evaluated the effects of craniectomy size on functional
o u t c ome s . Bo t h s t u d i e s c ompa r e d u n i l a t e r a l
frontotemporoparietal craniectomy (STC) with a bone flap
size of 12 × 15 cm to a limited smaller (LC) temporoparietal
craniectomy (8 × 6 cm). Jiang and colleagues [39] found STC
to be associated with lower mortality (26.2%) compared to LC
(35.1%; p < 0.05). GOS of 4–5 was reached by 39.8% of STC
patients compared to 28.6% of LC patients (p = 0.05). Further,
the incidence of delayed haematoma and incisional CSF fis-
tula significantly was lower in the STC group, while other
complications did not differ [39]. Qiu and colleagues [73]
found the STC to be associated with a larger reduction of
ICP. Mortality rates at 1 month after treatment were 27% in
the SLC and 57% in the LC group (p = 0.010). Good neuro-
logical outcome (GOS score of 4 to 5) rates 1 year after injury
for the groups were 56.8% and 32.4%, respectively (p =
0.035). The incidences of delayed intracranial haematoma
and subdural effusion were 21.6% and 10.8% versus 5.4%
and 0, respectively (p = 0.041 and 0.040) [73].
The topic of hinge craniotomy has already been discussed
in the section on primary DC for mass lesions and will not be
repeated here.
Consensus statement concerning surgical technique in DC
1. Skin incision should be larger than the intended cranioto-
my and pinna should be avoided (92%; 46/50)
2. Bone flap size should be large and incorporate removal of
bone to the middle cranial fossa floor for both unilateral
and bifrontal decompressive craniectomies (94%; 47/50)
3. The dura should be opened and primary dural closure
should not be performed (98%; 46/47)
4. Expansile dural graft should be used—sutured duraplasty
or onlay (91.5%; 43/47)
5. Avoidance of techniques that will contribute to secondary
injury is important, e.g. galeal adhesion to cerebral tissue,
migration of dural graft material, excessive graft or hemo-
static material volumes (86%; 43/50)
Areas of disagreement or uncertainty regarding surgical
technique in DC
1. The optimal materials for duraplasty
2. The necessity of sutured expansile duraplasty
3. The role of lobectomy/contusion removal
4. The method of bone flap storage
5. The removal of bone overlying the superior sagittal sinus
when performing bifrontal DC and superior sagittal sinus
division
6. The role of hinge craniotomy
Cranial reconstruction following DC (cranioplasty)
Cranial reconstruction (cranioplasty) following DC restores
the original skull contour. Large skull defects following trau-
ma DC leave the brain unprotected and hinder ICP regulation,
CSF dynamics and cerebral blood flow, potentially giving rise
to complications such as hydrocephalus and the syndrome of
the trephined [54,69].
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The importance of cranial reconstruction extends beyond
cosmesis. Cranioplasty offers brain protection and restores the
integrity of the calvarial vault and thus can restore normal cere-
brospinal fluid dynamics [53,54,111]. CT perfusion [107] and
transcranial Doppler ultrasonography [92] have shown improve-
ment in cerebral blood flow following cranioplasty. There are
nowmultiple reports, some specifically from TBI patient cohorts
[7,20,23,35,36,43,53,60,61,68,116], suggesting that cranioplasty
aids neurological recovery. Skull contour restoration is of partic-
ular importance to patients cosmetically and may improve their
psychosocial interactions and quality of life in general. It remains
unclear how timing of cranioplasty affects neurological recovery
as there is clear lack of class 1 evidence.
Cranioplasty operations carry a significant risk of postop-
erative complications, which can develop in the immediate
postoperative course or months and years later. The overall
rate of complications has been reported as 10.9–40.4%
[2,5,15,18,21,25,27,45,51,55,57,59,63,71,77,80,86,93,101,1-
04,105,109,115]. Autologous bone resorption may develop if
the devitalised bone flap does not come into contact with the
vascular bone edge and has been reported to occur with a
frequency of 0.7–17.7% [45,55,71,104,105]. Surgical site in-
fections are another concerning complication of cranioplasties
and are reported in 5–12.8% of cases [45,55,71,95,104,105].
The optimal timing for cranioplasty remains unclear.
Traditionally, surgeons would wait several months follow-
ing DC to allow for recovery from the initial neurological
insult and to ensure that cerebral oedema and inflammation
have subsided. Multiple observational studies of the timing
of cranioplasty have failed to detect a strong correlation
b e tw e e n t h e t im i n g a n d c omp l i c a t i o n s r a t e s
[2,5,15,18,21,25,27,45,51,55,57,59,63,71,77,80,86,93,95-
,101,104,105,109,115], and high-quality randomised trial
data are lacking.
The idealmaterial used for cranioplasty should be lightweight,
durable, malleable and easily fixable to the skull. A number of
materials have been used in cranial reconstruction, from autolo-
gous bone flap (either implanted in the anterior abdominal wall
or cryopreserved) to synthetic materials (methyl methacrylate,
polyethylene, ceramic, glass or titanium plates). Plates can be
made manually or, more recently, by using computer-based ad-
ditive manufacturing technology to produce customised patient-
specific implants. Despite the large number of studies in the
literature [30,42,72,87,96,98], solid data comparing the various
materials with regards to clinical outcome, patient satisfaction,
complication rates and costs are lacking.
Consensus statements concerning cranial reconstruction
following DC
1. Cranioplasty is required for limited brain protection and
reconstruction of the cranial contour. It can possibly im-
prove neurological outcome (88.2%; 45/51)
2. Patients should be surgically and medically optimised be-
fore performing cranioplasty (98%, 50/51)
3. Optimal timing for cranioplasty is not clear (82.4%; 42/51)
4. Early cranioplasty may be safe and beneficial and requires
further study (90.2%; 46/51)
5. There is no consensus on optimal material (96.1%; 49/51)
6. Cranioplasties are associated with significant compli-
cations and meticulous care (equal to other opera-
tions involving implants) should be exercised.
Cranioplasties should be performed by competent
surgeons (100%; 51/51)
Areas of disagreement or uncertainty regarding cranial
reconstruction following DC
1. The optimal timing of cranioplasty (i.e. early vs late) re-
mains unclear, with high-quality multi-centre studies
lacking.
2. The optimal material for cranioplasty remains unclear,
with high-quality multi-centre studies lacking.
3. A recent systematic review suggests that early
cranioplasty (within 3 months) is associated with greater
neurological improvement. This finding needs to be cor-
roborated by randomised trials.
DC in low- and middle-income countries
Trauma accounts for 9% of the world’s deaths. Approximately
90% of these injury-related deaths occur in low-income and
middle-income countries (LMICs). Injuries to the brain and
spine also result in millions of non-fatal injuries and conse-
quent disability. LMICs are experiencing the greatest rate of
increase in these injuries, largely because of road traffic acci-
dents. Incomplete collection of epidemiological data makes
quantification of the true worldwide magnitude and burden
of trauma and TBI very difficult, and the data presented above
may be underestimated. It is undeniable that TBI has signifi-
cant clinical, economic and societal implications
[28,65,79,81,91,114].
TBI care, including prevention, prehospital care,
specialised neurotrauma care and rehabilitation, is complex
and costly. In resource-constrained settings with limited or
inadequate infrastructure and professional capacity and with
fragile health systems with non-existent or poor social sup-
port, TBI treatment is even more challenging, and the appli-
cation of current treatment protocols and guidelines, devel-
oped largely in high-income countries, may not be readily
applicable [91]. Treatment paradigms need to be
contextualised for the relevant health system, taking into ac-
count societal, cultural and ethical considerations and accept-
able outcome measures.
Acta Neurochir
Intensive care, ICP monitors and facilities for utilising hy-
pothermia and barbiturate coma are not readily available in
many resource-poor settings. Neurosurgeons may be more
likely to use DC as a means of ICP control [81,91].
Consensus statement concerning DC in LMICs
1. The results of DECRA and RESCUEicp are not general-
izable to conditions in LMICs and as such cannot change
clinical practice in these areas (84.3%; 43/51)
2. We recognise and support that decisions about DC must
be made in context of local knowledge of access to med-
ical resources, capacity for long term care and cultural
beliefs (98%; 50/51)
3. We recognise that most DCs in LMICs are primary DCs
and support that due to limited resources valid indications
for DC may be made by the clinical condition of the
patient and the initial or most recent CT scan findings
(90.2%; 46/51)
4. The decision to perform aDC should bemade by the attend-
ing neurosurgeon responsible for the case (90.2%; 46/51)
5. DC is an invasive procedure with substantial potential for
harm and should be done by a neurosurgeon or a neuro-
surgical trainee who is adequately trained for the proce-
dure. Where neurosurgeons are not available, in excep-
tional circumstances, adequately trained surgeons may
perform the procedure (87.2%; 41/47)
6. Regional authorities should be encouraged to promote
availability of neurosurgeons to care for brain-injured pa-
tients (100%; 47/47)
Conclusions
DC has been in and out of vogue for many decades. Against a
background of a number of observational studies, two
randomised trials assessing the effectiveness of DC (DC) fol-
lowing TBI have now been published and yield class 1 evi-
dence. However, because there remain areas of uncertainty,
the first International Consensus Meeting on the Role of DC
in the Management of Traumatic Brain Injury was convened.
The consensus conference addressed six pre-specified themes:
(1) primary DC for mass lesions, (2) secondary DC for intra-
cranial hypertension, (3) perioperative care, (4) surgical tech-
nique, (5) cranial reconstruction and (6) DC in LMICs. We
have provided consensus statements to aid decision-making
and also flagged areas of disagreement or uncertainty which
require further investigation. In particular, the vast majority of
studies have been conducted in high-income countries even
though 89% of head injuries occur in LMICs. Hence, caution
is required in applying evidence to management across the
globe. Further research is required in several areas, including
primary DC, the role of hinge craniotomy and the optimal
timing and material for skull reconstruction.
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